P. Spiess

发表

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

F. Marincola, S. Rosenberg, P. Hwu, 1998, Nature Medicine.

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

S. Rosenberg, P. Spiess, R. Lafrenière, 1986, Science.

Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer

M. Nishimura, P. Spiess, T. Clay, 1999, Pathology & Oncology Research.

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.

S. Rosenberg, Y. Zhai, P. Spiess, 1996, Journal of immunology.

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

S. Rosenberg, J. Mulé, N. Restifo, 1992, The Journal of experimental medicine.

De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.

K. Irvine, Julie A Hong, D. Schrump, 2006, Cancer research.

Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella Typhimurium

S. Rosenberg, D. Kleiner, P. Spiess, 2002, Journal of immunotherapy.

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

S. Rosenberg, C. Klebanoff, N. Restifo, 2005, The Journal of experimental medicine.

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.

S. Rosenberg, M. Nishimura, K. Irvine, 1995, Cancer research.

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

F. Marincola, P. Matzinger, N. Restifo, 2002, The Journal of Immunology.

Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes.

E. Oldfield, P. Spiess, S. Walbridge, 1992, Journal of neurosurgery.

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

S. Rosenberg, P. Spiess, J. Yang, 1987, Journal of the National Cancer Institute.

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.

S. Rosenberg, M. Nishimura, Y. Zhai, 1997, Journal of immunotherapy.

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action

R. Cameron, S. Rosenberg, P. Spiess, 1990, The Journal of experimental medicine.

IN VIVO ADMINISTRATION OF INTERLEUKIN‐2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSES

S. Rosenberg, S. Schwarz, P. Spiess, 1983, Transplantation.

In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

S. Rosenberg, P. Spiess, I. Yron, 1980, Journal of immunology.

Identification of a T-cell receptor from a therapeutic murine T-cell clone.

S. Rosenberg, M. Nishimura, J. Mulé, 1997, Journal of immunotherapy.

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes.

S. Rosenberg, S. Schwarz, P. Spiess, 1988, Journal of the National Cancer Institute.

In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens.

S. Rosenberg, S. Schwarz, P. Spiess, 1978, Journal of immunology.

a Peptide Vaccine Patients with Metastatic Melanoma Receiving Generation of Antitumor Reactivity in Impact of Cytokine Administration on the

F. Marincola, S. Rosenberg, P. Hwu, 1999 .

Interferon y and Tumor Necrosis Factor Have a Role in Tumor Regressions Mediated by Murine CD8+ Tumor-infiltrating Lymphocytes

S. Rosenberg, J. Mull, P. Spiess, 2003 .

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

S. Rosenberg, C. Klebanoff, N. Restifo, 2003, The Journal of experimental medicine.

A simplified method for the production of murine T-cell growth factor free of lectin.

S. Rosenberg, P. Spiess, 1981, Journal of immunological methods.

In vitro growth of murine T cells. I. Production of factors necessary for T cell growth.

S. Rosenberg, S. Schwarz, P. Spiess, 1978, Journal of immunology.

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.

S. Rosenberg, J. Mulé, P. Spiess, 1986, Cancer research.

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells

T. Waldmann, S. Rosenberg, C. Klebanoff, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2

S. Rosenberg, J. Mulé, S. Schwarz, 1985, The Journal of experimental medicine.

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

S. Rosenberg, J. Mulé, P. Spiess, 1991, The Journal of experimental medicine.

In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells.

S. Rosenberg, S. Schwarz, P. Spiess, 1980, Cellular immunology.

Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer

S. Rosenberg, C. Klebanoff, N. Restifo, 2004, Journal of leukocyte biology.

In vitro growth of murine T cells. III. Method for separation of T cell growth factor (TCGF) from concanavalin A and biological activity of the resulting TCGF.

S. Rosenberg, S. Schwarz, P. Spiess, 1980, Journal of immunological methods.

In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes.

R. Puri, B. Fox, S. Rosenberg, 1990, Journal of biological response modifiers.

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

S. Rosenberg, L. Muul, P. Spiess, 1987, Journal of immunology.

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.

F. Marincola, S. Rosenberg, P. Hwu, 1999, Journal of immunology.

Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor

T. Eberlein, S. Rosenberg, P. Spiess, 1982, Cancer Immunology, Immunotherapy.

Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.

T. Eberlein, S. Rosenberg, P. Spiess, 1982, Journal of the National Cancer Institute.

Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.

S. Rosenberg, N. Restifo, P. Spiess, 1994, Cancer research.

Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.

S. Hewitt, E. Turner, H. Alexander, 2003, Cancer research.

Reduction of preexisting transplantation immunity by specific pregnancy.

P. Spiess, E. J. Breyere, 1973, Transplantation.

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

S. Rosenberg, J. Mulé, P. Spiess, 1991, The Journal of experimental medicine.

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

S. Rosenberg, C. Klebanoff, N. Restifo, 2005, The Journal of experimental medicine.